Portfolio

The Next Generation
of Innovators

All

Biotech | Exited/Public

Gene therapy company developing next-generation AAV vectors

medtech | Current

Integrated embolic protection systems

Biotech | Exited/Public

Treatement for the root cause of transthyretin amyloidosis

medtech | Exited/Public

Transforming the vascular closure market

medtech | Current

Transcervical treatment for symptomatic uterine fibroids

medtech | Current

Transforming the treatment of heart failure

medtech | Exited/Public

First fully implantable treatment for sleep apnea

MEDtech | CURRENT

Negative pressure device to treat postpartum hemorrhage

medtech | Current

Bio-engineered implant for ACL resotration

biotech | Exited/Public

Rationally designed small molecule protein degraders

medtech | Current

Novel treatment for chronic pain in lower limb amputees

medtech | Current

Innovative neuromodulation therapy for severe migraine headaches

MEDtech | Current

Innovative artificial cervical disc replacement device

biotech | Current

Precision therapies for genetic heart diseases

MEDTECH

medtech | Current

Integrated embolic protection systems

medtech | Exited/Public

Transforming the vascular closure market

medtech | Current

Transcervical treatment for symptomatic uterine fibroids

medtech | Current

Transforming the treatment of heart failure

medtech | Exited/Public

First fully implantable treatment for sleep apnea

medtech | Current

Negative pressure device to treat postpartum hemorrhage

medtech | Current

Bio-engineered implant for ACL resotration

medtech | Current

Novel treatment for chronic pain in lower limb amputees

medtech | Current

Innovative neuromodulation therapy for severe migraine headaches

medtech | Current

Innovative artificial cervical disc replacement device
BIOTECH

Biotech | Exited/Public

Gene therapy company developing next-generation AAV vectors

Biotech | Exited/Public

Treatement for the root cause of transthyretin amyloidosis

biotech | Current

Precision therapies for genetic heart diseases

biotech | Exited/Public

Rationally designed small molecule protein degraders

CURRENT

medtech | Current

Integrated embolic protection systems

medtech | Current

Transcervical treatment for symptomatic uterine fibroids

medtech | Current

Transforming the treatment of heart failure

medtech | Current

Negative pressure device to treat postpartum hemorrhage

medtech | Current

Bio-engineered implant for ACL resotration

medtech | Current

Novel treatment for chronic pain in lower limb amputees

medtech | Current

Innovative neuromodulation therapy for severe migraine headaches

MEDtech | Current

Innovative artificial cervical disc replacement device

biotech | Current

Precision therapies for genetic heart diseases

EXITED/PUBLIC

Biotech | Exited/Public

Gene therapy company developing next-generation AAV vectors

Biotech | Exited/Public

Treatement for the root cause of transthyretin amyloidosis

medtech | Exited/Public

Transforming the vascular closure market

medtech | Exited/Public

First fully implantable treatment for sleep apnea

Biotech | Exited/Public

Rationally designed small protein degraders

Please note that this list includes only private company investments and excludes any public company investments.